Roux-en-Y胃旁路手术后胰岛素抵抗的丧失:一项时间进程研究。

Loss of insulin resistance after Roux-en-Y gastric bypass surgery: a time course study.

作者信息

Wickremesekera Kusal, Miller Geoff, Naotunne Tissa Desilva, Knowles Graham, Stubbs Richard S

机构信息

Wakefield Gastroenterology Centre, Wakefield Hospital, Wellington, New Zealand.

出版信息

Obes Surg. 2005 Apr;15(4):474-81. doi: 10.1381/0960892053723402.

Abstract

BACKGROUND

Gastric bypass has repeatedly been shown to improve and even cure type 2 diabetes by substantially improving insulin resistance. The mechanism by which it achieves this is not currently known, but some have hypothesized that there may be important humoral effects brought about by the bypass of the stomach, duodenum or proximal jejunum. A better understanding of the time course of the changes in insulin resistance after surgery might assist our understanding of potential mechanisms.

METHODS

Intravenous glucose tolerance tests (IVGTT) were performed in 26 severely obese patients on the morning of gastric bypass surgery and again 6 days later. In addition insulin resistance was assessed in 71 patients undergoing gastric bypass surgery by the homeostasis model assessment (HOMA) method before surgery, and again at 6 days, 3, 6, 9, and 12 months. Patients were divided into 3 groups for analysis: diabetics, impaired glucose tolerance and normal glucose tolerance.

RESULTS

All 3 groups of patients were noted to have insulin resistance prior to surgery. This was greatest in the diabetic patients, as indicated by HOMA. There was marked loss of/improvement in insulin resistance within 6 days of gastric bypass by both IVGTT and HOMA methods in all groups, which was maintained over the 12-month period. The study included 31 diabetic patients, of whom only 3 required medication following hospital discharge.

CONCLUSION

The changes in insulin resistance seen after gastric bypass, which are responsible for the resolution or improvement of type 2 diabetes occur within 6 days of the surgery, before any appreciable weight loss has occurred. This finding has implications for our understanding of the mechanism of insulin resistance in severely obese patients and is consistent with a humoral mechanism emanating from the GI tract.

摘要

背景

胃旁路手术已多次被证明可通过显著改善胰岛素抵抗来改善甚至治愈2型糖尿病。目前尚不清楚其实现这一目标的机制,但一些人推测,胃、十二指肠或空肠近端的旁路可能会产生重要的体液效应。更好地了解手术后胰岛素抵抗变化的时间进程可能有助于我们理解潜在机制。

方法

对26例严重肥胖患者在胃旁路手术当天上午及术后6天进行静脉葡萄糖耐量试验(IVGTT)。此外还采用稳态模型评估(HOMA)方法对71例接受胃旁路手术的患者术前、术后6天、3个月、6个月、9个月和12个月的胰岛素抵抗情况进行评估。患者分为3组进行分析:糖尿病患者、糖耐量受损患者和糖耐量正常患者。

结果

所有3组患者术前均存在胰岛素抵抗。如HOMA所示,糖尿病患者的胰岛素抵抗最为严重。所有组在胃旁路手术后6天内,通过IVGTT和HOMA方法均显示胰岛素抵抗显著降低/改善,并在12个月内保持。该研究包括31例糖尿病患者,其中只有3例出院后需要药物治疗。

结论

胃旁路手术后出现的胰岛素抵抗变化导致2型糖尿病得到缓解或改善,这种变化在手术后6天内出现,此时尚未出现明显体重减轻。这一发现有助于我们理解严重肥胖患者胰岛素抵抗的机制,并且与源自胃肠道的体液机制相一致。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索